Delivery Order SPE2DB22D2206-SPE2DB25FJA20
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Carvedilol ER 20 mg capsules (30-count units) valued at $2,280.42 under a firm fixed-price contract. The award, issued on September 12, 2025, with an ultimate completion date of September 15, 2025, represents a non-set-aside competitively awarded procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical federal medical supplier,...
- The Defense Logistics Agency awarded a delivery order valued at $1,401.21 to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Carvedilol ER 40 mg capsules (30-count units). This contract is a firm fixed-price delivery order with an ultimate completion date of August 6, 2025, and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order valued at $3,919.30 to AmerisourceBergen Drug Corp for Carvedilol ER 10 mg capsules (30-count units) on September 17, 2025, with an ultimate completion date of September 18, 2025. This firm fixed price, competitively awarded contract represents a non-set-aside procurement and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Carvedilol ER 40 mg capsules (30-count units) with a ceiling value of $6,612.84. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of July 29, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete purchase under a larger federal contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Carvedilol ER 40 mg capsules (30-count units) with a contract value of $4,019.94 and a completion date of September 22, 2025. This is a firm fixed-price, non-competitive set-aside delivery order utilizing AmerisourceBergen's existing indefinite delivery contract vehicle with DLA Troop Support Medical. The order will be fulfilled at the contractor's facility in...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Carvedilol ER 40 mg capsules (30-count units) with a ceiling value of $4,628.35. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The performance location...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Carvedilol ER 10 mg capsules (30-count) under a firm fixed price contract valued at $1,358.25. The order was awarded on July 25, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside competitive award reflects AmerisourceBergen's established role as a critical pharmaceutical supplier to federal medical procurement, with performance occurring at the company's corporate headquarters in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Carvedilol ER 40 mg capsules (30-count packages) with a contract ceiling value of $4,407.82. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement under the...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 80 mg capsules (30-count units) valued at $2,118.65. This competitive, non-set-aside award, issued on September 16, 2025, represents a firm fixed price delivery order with an ultimate completion date of September 17, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 80 mg capsules (30-count) with a ceiling value of $5,662.73. This is a firm fixed price delivery order with an ultimate completion date of September 18, 2025, issued on September 17, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJA20Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 40 mg capsules (30-count units) under a firm fixed-price contract valued at $6,227.92. This non-set-aside award, effective July 22, 2025, with an ultimate completion date of July 23, 2025, represents a routine pharmaceutical procurement to support federal military and healthcare operations. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving the Defense Health Agency and military healthcare systems. This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and running through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The company's extensive federal contract portfolio demonstrates its established capability to fulfill competitive procurement requirements across multiple therapeutic domains, from specialty medications to vaccines and medical devices, supporting defense and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.2k | 7/22/25 |